Why is Remedium Life falling/rising?

As of 15-Jul, Remedium Lifecare Ltd's stock price is currently at 1.21, reflecting an increase of 0.02 or 1.68%. The stock has shown a strong performance recently, gaining 44.05% over the last 15 days and outperforming its sector by 0.5% today. However, despite this short-term rise, the stock has a troubling long-term outlook, with a year-to-date decline of 66.15% and a staggering 89.46% drop over the past year. The company has reported consistent losses, with a negative return on capital employed (ROCE) and a high debt-to-EBITDA ratio, indicating a low ability to service its debt. These negative factors contribute to a perception of risk surrounding the stock, despite its recent gains.
In the broader market context, while Remedium Lifecare's stock has outperformed the Sensex by 7.08% over the past week, the benchmark itself has declined by 1.36%. This indicates that the stock's recent rise is somewhat isolated, as the overall market is experiencing a downturn. The company's liquidity appears sufficient for trading, but the falling investor participation, with a significant drop in delivery volume, raises concerns about sustained interest in the stock. Overall, while there are short-term gains, the long-term performance and financial health of Remedium Lifecare Ltd suggest a challenging environment ahead.